New Research In
Physical Sciences
Social Sciences
Featured Portals
Articles by Topic
Biological Sciences
Featured Portals
Articles by Topic
- Agricultural Sciences
- Anthropology
- Applied Biological Sciences
- Biochemistry
- Biophysics and Computational Biology
- Cell Biology
- Developmental Biology
- Ecology
- Environmental Sciences
- Evolution
- Genetics
- Immunology and Inflammation
- Medical Sciences
- Microbiology
- Neuroscience
- Pharmacology
- Physiology
- Plant Biology
- Population Biology
- Psychological and Cognitive Sciences
- Sustainability Science
- Systems Biology
High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas

Abstract
Malignant mesotheliomas (MMs) are aggressive tumors that develop most frequently in the pleura of patients exposed to asbestos. In contrast to many other cancers, relatively few molecular alterations have been described in MMs. The most frequent numerical cytogenetic abnormality in MMs is loss of chromosome 22. The neurofibromatosis type 2 gene (NF2) is a tumor suppressor gene assigned to chromosome 22q which plays an important role in the development of familial and spontaneous tumors of neuroectodermal origin. Although MMs have a different histogenic derivation, the frequent abnormalities of chromosome 22 warranted an investigation of the NF2 gene in these tumors. Both cDNAs from 15 MM cell lines and genomic DNAs from 7 matched primary tumors were analyzed for mutations within the NF2 coding region. NF2 mutations predicting either interstitial in-frame deletions or truncation of the NF2-encoded protein (merlin) were detected in eight cell lines (53%), six of which were confirmed in primary tumor DNAs. In two samples that showed NF2 gene transcript alterations, no genomic DNA mutations were detected, suggesting that aberrant splicing may constitute an additional mechanism for merlin inactivation. These findings implicate NF2 in the oncogenesis of primary MMs and provide evidence that this gene can be involved in the development of tumors other than nervous system neoplasms characteristic of the NF2 disorder. In addition, unlike NF2-related tumors, MM derives from the mesoderm; malignancies of this origin have not previously been associated with frequent alterations of the NF2 gene.
Citation Manager Formats
Sign up for Article Alerts
Jump to section
You May Also be Interested in
More Articles of This Classification
Related Content
Cited by...
- Inflammation-Related IL1{beta}/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma
- Genome-based Mutational Analysis by Next Generation Sequencing in Patients with Malignant Pleural and Peritoneal Mesothelioma
- Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma
- YAPing Hippo Forecasts a New Target for Lung Cancer Prevention and Treatment
- Current Issues in Malignant Pleural Mesothelioma Evaluation and Management
- Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma
- The Hippo signaling pathway in stem cell biology and cancer
- Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship
- Tumor Suppressor Alterations Cooperate to Drive Aggressive Mesotheliomas with Enriched Cancer Stem Cells via a p53-miR-34a-c-Met Axis
- Tumor Suppressor NF2/Merlin Is a Microtubule Stabilizer
- Group I p21-Activated Kinases (PAKs) Promote Tumor Cell Proliferation and Survival through the AKT1 and Raf-MAPK Pathways
- New Strategies in Pleural Mesothelioma: BAP1 and NF2 as Novel Targets for Therapeutic Development and Risk Assessment
- TGF-{beta} synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
- Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma
- Genomic gains and losses in malignant mesothelioma demonstrated by FISH analysis of paraffin-embedded tissues
- LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma
- Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung Adenocarcinoma
- Loss of the Tumor Suppressor Gene NF2, Encoding Merlin, Constitutively Activates Integrin-Dependent mTORC1 Signaling
- Identification and Characterization of Putative Tumor Suppressor NGB, a GTP-Binding Protein That Interacts with the Neurofibromatosis 2 Protein
- Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin
- The NF2 Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 Expression
- Neurofibromatosis 2 and malignant mesothelioma
- p21-activated Kinase Links Rac/Cdc42 Signaling to Merlin
- Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2
- Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus
- Cloning and Characterization of SCHIP-1, a Novel Protein Interacting Specifically with Spliced Isoforms and Naturally Occurring Mutant NF2 Proteins
- Deletions of Chromosome 4 at Multiple Sites Are Frequent in Malignant Mesothelioma and Small Cell Lung Carcinoma
- Comparative Genomic Hybridization and Loss of Heterozygosity Analyses Identify a Common Region of Deletion at 15q11.1-15 in Human Malignant Mesothelioma
- p21-activated Kinase Links Rac/Cdc42 Signaling to Merlin